[Lung volume reduction surgery for severe emphysema treatment]

Area of Science:

• Pulmonology
• Thoracic Surgery
• Respiratory Medicine

Background:

• Severe emphysema significantly impacts patient quality of life and survival.
• Lung volume reduction surgery (LVRS) has emerged as a critical intervention.
• The National Emphysema Treatment Trial (NETT) provided foundational evidence for LVRS efficacy.

Purpose of the Study:

• To evaluate the long-term effectiveness and safety of LVRS in severe emphysema.
• To assess improvements in symptomatic relief and survival post-LVRS.
• To analyze outcomes in diverse patient subgroups, including those previously considered high-risk.

Main Methods:

• Review of multicentre randomized trials and subsequent observational studies.
• Analysis of symptomatic outcomes and survival data following LVRS.
• Assessment of post-operative mortality rates and contributing factors.

Main Results:

• LVRS demonstrated significant reductions in emphysema symptoms.
• Improved survival was observed in selected patients with heterogeneous emphysema.
• Recent studies confirm positive symptomatic and survival outcomes in high-risk patients.
• Post-operative mortality following LVRS is now minimal.

Conclusions:

• LVRS is a safe and effective treatment for severe emphysema.
• Advances in minimally invasive techniques have enhanced patient outcomes.
• LVRS offers a valuable therapeutic option for improving lung function and longevity.